Clinical features and pulmonary infections of diffuse alveolar hemorrhage in rheumatic disease patients
PLOS One · 2025
DOI: 10.1371/journal.pone.0339183 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Carla Marina Román-Montes und 5 weiteren Autor:innen. Beteiligte Einrichtung: Infectious Diseases Department, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico. Hauptthemen laut MEDLINE: Hemorrhage, Rheumatic Diseases, Lung Diseases, Pulmonary Alveoli. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Diffuse alveolar hemorrhage (DAH) is an uncommon but potentially life-threatening pulmonary complication in patients with rheumatic diseases (RD). Immunosuppression, endothelial injury, and systemic inflammation may increase the risk of pulmonary infections, further complicating clinical management and worsening outcomes.
Objective
To describe the prevalence and factors associated with pulmonary infections in patients with DAH and RD.
Methods
We conducted a retrospective, cross-sectional study including patients diagnosed with DAH and underlying RD at a tertiary care center in Mexico between 2003 and 2023. A logistic regression model was used to identify factors associated with infection.
Results
Seventy-three patients with DAH were included; 31.5% had concurrent pulmonary infection. Systemic lupus erythematosus (68.5%) and ANCA-associated vasculitis (29%) were the most common underlying diseases. Evidence of hemorrhage in bronchoalveolar lavage was significantly more frequent in the infection group (76% vs. 48%; p = 0.02). Bacterial infection was the most common, occurring in 62% of cases, followed by fungal infection at 21%. The 30-day mortality rate was 10%, and infection was not an independent predictor of death. A multivariable logistic regression analysis revealed that male sex (OR 9.8; 95% CI: 2.7–35.3; p < 0.01) and IMV requirement (OR 8.8; 95% CI: 1.7–46.9; p = 0.01) were significantly associated with pulmonary infection.
Conclusion
Pulmonary infections are common in patients with DAH and RD. A relatively low short-term mortality rate was observed in this cohort. Male sex and IMV requirement were associated with infections. Early microbiological assessment and targeted therapy are crucial to optimizing outcomes in this vulnerable population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Infectious Diseases Department, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
- Immunology and Rheumatology Department, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
ORCID-Profile: Carla Marina Román-Montes, Shaul Ariel Navarro-Lara, Guillermo Arturo Guaracha-Basañez
Zitieren
APA
Román-Montes, C. M., Briones-García, E., Navarro-Lara, S. A., Ortiz-Bustamante, M. A., García-Herrera, I. P., & Guaracha-Basañez, G. A. (2025). Clinical features and pulmonary infections of diffuse alveolar hemorrhage in rheumatic disease patients. PLOS One. https://doi.org/10.1371/journal.pone.0339183
Vancouver
Román-Montes CM, Briones-García E, Navarro-Lara SA, Ortiz-Bustamante MA, García-Herrera IP, Guaracha-Basañez GA. Clinical features and pulmonary infections of diffuse alveolar hemorrhage in rheumatic disease patients. PLOS One. 2025. doi:10.1371/journal.pone.0339183
BibTeX
@article{RomnMontes2025,
author = {Román-Montes, Carla Marina and Briones-García, Eduardo and Navarro-Lara, Shaul Ariel and Ortiz-Bustamante, Marco Antonio and García-Herrera, Iris Paola and Guaracha-Basañez, Guillermo Arturo},
title = {Clinical features and pulmonary infections of diffuse alveolar hemorrhage in rheumatic disease patients},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0339183}
}
EUVIMED